🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is evaluating a new drug called "ixazomib" as a possibl...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10
Trial ID
NCT02916771
Treatments Being Tested
This study will assess the efficacy of daratumumab in combination with ixaz...
Status
Unknown
Location
General Hospital of Athens "Alexandra"
Start Date
2018-12
Trial ID
NCT03746652
Treatments Being Tested
The purpose of this pilot study is to examine changes in patient-reported o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-05
Trial ID
NCT03903406
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
The purpose of Phase 1 of this study was to determine the safety, tolerabil...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2010-11-22
Trial ID
NCT01217957
Treatments Being Tested
This study evaluates a new treatment combination of ixazomib with cyclophos...
Status
Completed
Location
Queen Elizabeth Medical Centre
Start Date
2015-12
Trial ID
NCT02461888
Treatments Being Tested
This is a phase II, multicenter, open-label study to evaluate the safety an...
Status
Completed
Location
CHRU - Hôpital du Haut Lévêque
Start Date
2014-11-12
Trial ID
NCT01936532
Treatments Being Tested
A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2019-08-09
Trial ID
NCT04068597
The purpose of this study is to determine the safety, tolerability, maximum...
Status
Completed
Location
UCSF Medical Center
Start Date
2011-10-31
Trial ID
NCT01383928
Treatments Being Tested